Athena Athena

X
[{"orgOrder":0,"company":"ACRO Biomedical","sponsor":"Not Applicable","pharmaFlowCategory":"DU","amount":"Not Applicable","upfrontCash":"Not Applicable","newsHeadline":"ACRO Biomedical to Conduct Trials on Acellular Cornea Product","therapeuticArea":"Ophthalmology","highestDevelopmentStatus":"Undisclosed","country":"TAIWAN","productType":"Undisclosed","productStatus":"Undisclosed","date":"July 2020","url1":"","url2":"","graph1":"Ophthalmology","graph2":"Undisclosed"}]

Find Clinical Drug Pipeline Developments & Deals by ACRO Biomedical

Menu
Loading...
Filters Filter
×
FILTER:
filter Company
    filter Sponsor
      filter Country
        filter Therapeutic Area
          filter Study Phase

            Active Filter(s):

            Companies By Therapeutic Area

            Development Status

            Details:

            ACRO has successfully performed world’s first canine corneal transplantation using ABCcolla® Collagen Ophthalmic Matrix.

            Lead Product(s): Collagen Ophthalmic Matrix

            Therapeutic Area: Ophthalmology Product Name: ABCcolla

            Highest Development Status: Undisclosed Product Type: Undisclosed

            Partner/Sponsor/Collaborator: Not Applicable

            Deal Size: Not Applicable Upfront Cash: Not Applicable

            Deal Type: Not Applicable July 24, 2020

            ASK
            US
            PHARMACOMPASS
            Upload
            your Pipeline Activity
            Post Enquiry
            POST ENQUIRY